Research Progress on the Mechanism of Bile Acids and Their Receptors in Depression
International Journal of Molecular Sciences · 24.04.2025 · 26 (9) · 4023
DOI: 10.3390/ijms26094023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.04.2025. Verfasst von Xue Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China. Hauptthemen laut MEDLINE: Bile Acids and Salts, Depression, Receptors, G-Protein-Coupled, Receptors, Cytoplasmic and Nuclear. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing-Tianjin-Hebei Basic Research Cooperation Project.
Themen: Depression
Abstract (Originalsprache)
Depression, a highly prevalent mental disorder worldwide, arises from multifaceted interactions involving neurotransmitter imbalances, inflammatory responses, and gut–brain axis dysregulation. Emerging evidence highlights the pivotal role of bile acids (BAs) and their receptors, including farnesoid X receptor (FXR), Takeda G protein-coupled receptor 5 (TGR5), and liver X receptors (LXRs) in depression pathogenesis through modulation of neuroinflammation, gut microbiota homeostasis, and neural plasticity. Clinical investigations demonstrated altered BA profiles in depressed patients, characterized by decreased primary BAs (e.g., chenodeoxycholic acid (CDCA)) and elevated secondary BAs (e.g., lithocholic acid (LCA)), correlating with symptom severity. Preclinical studies revealed that BAs ameliorate depressive-like behaviors via dual mechanisms: direct CNS receptor activation and indirect gut–brain signaling, regulating neuroinflammation, oxidative stress, and BDNF/CREB pathways. However, clinical translation faces challenges including species-specific BA metabolism, receptor signaling complexity, and pharmacological barriers (e.g., limited blood–brain barrier permeability). While FXR/TGR5 agonists exhibit neuroprotective and anti-inflammatory potential, their adverse effects (pruritus, dyslipidemia) require thorough safety evaluation. Future research should integrate multiomics approaches and interdisciplinary strategies to develop personalized BA-targeted therapies, advancing novel treatment paradigms for depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- School of Acupuncture & Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China.
- Hebei Key Laboratory of Early Life Health Promotion, Hebei Medical University, Shijiazhuang 050031, China.
- National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence Research, Peking University, Beijing 100191, China.
Förderung
- National Natural Science Foundation of China
- Beijing-Tianjin-Hebei Basic Research Cooperation Project
Zitieren
APA
Zhao, X., Zheng, I., Huang, W., Tang, D., Zhao, M., Hou, R., Huang, Y., Shi, Y., Zhu, W., & Wang, S. (2025). Research Progress on the Mechanism of Bile Acids and Their Receptors in Depression. International Journal of Molecular Sciences, 26(9), 4023. https://doi.org/10.3390/ijms26094023
Vancouver
Zhao X, Zheng I, Huang W, Tang D, Zhao M, Hou R, et al. Research Progress on the Mechanism of Bile Acids and Their Receptors in Depression. International Journal of Molecular Sciences. 2025;26(9):4023. doi:10.3390/ijms26094023
BibTeX
@article{Zhao2025,
author = {Zhao, Xue and Zheng, Iin and Huang, Wenjing and Tang, Dongning and Zhao, Meidan and Hou, Ruiling and Huang, Ying and Shi, Yun and Zhu, Weili and Wang, Shenjun},
title = {Research Progress on the Mechanism of Bile Acids and Their Receptors in Depression},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4023},
doi = {10.3390/ijms26094023}
}
EUVIMED